Financial Statements

IDEXX Laboratories, Inc. (IDXX)

$363.37

+6.04 (+1.69%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 2,1761,5961,168804-
Net Income 745582428377263
Stock Dividends --2--13540
Dividend Paid -----
Retained Earnings 2,9202,1761,5961,168804

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 646614437379-
Annual Depreciation 166140332181456
Capital Expenditure -120-108-155-123-77
Net PPE 693646614437379

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -200214240243
New Purchases -334-0---
Intangible and Goodwill 200214240243359

IDEXX Laboratories, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes IDEXX Laboratories, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.